FSH, or follicle-stimulating hormone, has no single “normal” number. What counts as a healthy level shifts dramatically depending on your age, your sex, and, if you menstruate, where you are in your cycle. In women of reproductive age, a typical early-cycle FSH reading falls roughly between 3 and 10 mIU/mL, while postmenopausal levels routinely climb above 40 mIU/mL. In men, the commonly cited lab range runs from about 1.5 to 12 mIU/mL, but recent research suggests that even values within that range can signal trouble for fertility. Understanding what your number actually means requires knowing which life stage the lab was comparing you against.
What FSH Does and Why It Changes
FSH is produced by the pituitary gland at the base of the brain. Its core job is to stimulate the gonads: in women it drives the growth and maturation of ovarian follicles each month, and in men it supports sperm production in the testes. FSH operates inside a feedback loop known as the hypothalamic-pituitary-gonadal axis, where hormones from the brain and the gonads constantly adjust one another’s output. When the ovaries or testes produce enough sex steroids, those hormones signal the pituitary to dial FSH back. When gonadal output drops, the pituitary compensates by pushing FSH higher.
1PubMed Central. Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signallingThis feedback mechanism is the reason FSH tells a story about your reproductive health. A very high FSH in a young woman may mean the ovaries are not responding well, forcing the pituitary to work harder. A very low FSH might mean the brain itself is underperforming. The number alone is not a diagnosis, but it points clinicians toward the right part of the system to investigate.
Infancy Through Puberty
Most people assume FSH stays flat and low throughout childhood, but the pattern is actually more interesting. In female infants, FSH values can scatter widely during the first months of life, with some readings reaching into the adult range during a brief hormonal surge sometimes called “mini-puberty.” After that early spike, levels decline through childhood and stay low until the onset of clinical puberty, when FSH climbs again to adult concentrations.
2Pediatric Research. Pituitary-Gonadal Relations in Female Children and AdolescentsThis pattern matters clinically because unexpectedly high FSH during mid-childhood can be an early flag for conditions like Turner syndrome. In one study, abnormally elevated FSH was found in the majority of girls with Turner syndrome during both early and mid-childhood, well before other symptoms became obvious.
3PubMed Central. FSH may be a useful tool to allow early diagnosis of Turner syndromeIn boys, the childhood trajectory is similar: FSH stays low until puberty triggers the hypothalamic-pituitary-gonadal axis to reactivate, sending gonadotropin pulses that drive testicular growth and, eventually, sperm production. When puberty arrives unusually early or unusually late, FSH measurement is one of the first tools clinicians reach for, because it reveals whether the central hormonal signaling system has switched on.
4PubMed Central. Critical appraisal of diagnostic laboratory tests in the evaluation of central precocious pubertyFemale Reproductive Years and Cycle Timing
If you are a woman between roughly 18 and 40 with regular periods, your FSH level is a moving target within each menstrual cycle. Levels rise early in the follicular phase as follicles begin to grow, drop to a low point just before ovulation, then spike again in a brief mid-cycle peak that typically coincides with the LH surge. In classic research tracking daily hormone levels, the mid-cycle FSH peak averaged about 20 mIU/mL, while luteal-phase levels were markedly lower and continued to decline until a late-luteal rise just before the next period began.
5The Journal of Clinical Endocrinology & Metabolism. Daily Variations in Plasma Follicle Stimulating Hormone, Luteinizing Hormone and Progesterone in the Normal Menstrual CycleThis is why fertility clinics draw blood on day 2 or day 3 of your cycle for a “basal” FSH reading. The early follicular phase is the most stable window, giving the clearest snapshot of baseline pituitary output before the ovaries start actively producing estrogen and inhibin for that cycle. A random mid-cycle blood draw could catch the ovulatory spike and look alarmingly high even though nothing is wrong.
FSH, Fertility, and Ovarian Reserve
Day-3 FSH became one of the earliest widely used markers for predicting how well a woman would respond to fertility treatment. In a landmark study of IVF patients, women with a basal FSH below 15 mIU/mL had ongoing pregnancy rates of about 17% per attempt, those with levels between 15 and 25 mIU/mL had rates around 9%, and those above 25 mIU/mL had rates of only about 4%.
6PubMed. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcomeHigh basal FSH essentially signals that the ovaries have fewer follicles left to recruit, so the pituitary has to shout louder to get a response. But an important nuance emerged from later research: elevated FSH reflects a reduction in the quantity of eggs, not necessarily their quality. In cycling women with high FSH, decent pregnancy and live-birth rates could still be achieved, especially in younger patients. Clinics that refuse to treat women with elevated basal FSH may be denying them a real, if lower, chance of conceiving with their own eggs.
7Human Reproduction. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserveThe ratio of FSH to LH on day 3 also carries information, though its usefulness depends on age. In older women undergoing IVF, an elevated FSH-to-LH ratio predicted fewer good-quality embryos and lower pregnancy rates. In younger women, the same ratio did not reliably predict outcomes.
8PubMed Central. Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older womenIt is worth knowing that FSH has been partly displaced as the go-to ovarian reserve marker. Anti-Müllerian hormone (AMH) does not fluctuate with the menstrual cycle the way FSH does, which makes it more convenient and sometimes more informative. One study of women undergoing fertility treatment found that among patients under 35, basal FSH was the stronger predictor of pregnancy, while among women 35 and older, AMH was more predictive.
9PubMed Central. FSH versus AMH: age-related relevance to ICSI resultsThe Perimenopausal Roller Coaster
Perimenopause is when FSH numbers become genuinely difficult to interpret. As the ovarian follicle pool shrinks in the years before menopause, the pituitary ramps up FSH production. This increase begins roughly six years before a woman’s final menstrual period and eventually reaches a plateau that is nearly 14 times the level seen in men.
10PubMed Central. Follicle-stimulating hormone: More than a marker for menopause: FSH as a frontier for women’s mental healthThe trouble is that perimenopausal FSH does not rise in a smooth, predictable line. In women still having irregular periods, early follicular FSH can fluctuate wildly from one month to the next. A single reading might land in the postmenopausal range and then drop back to levels seen in younger fertile women a cycle later. Only once periods have been absent for at least three months does the upward trend become more uniform.
11Menopause. Cycle and hormone changes during perimenopause: the key role of ovarian functionThis volatility means a single FSH blood draw during perimenopause is nearly useless for telling you where you stand. A study tracking perimenopausal hormone excretion found values ranging from about 4 to 32 IU in perimenopausal women compared with 3 to 7 IU in younger women, a huge spread that underscores how unreliable any single measurement is during this window.
12The Journal of Clinical Endocrinology & Metabolism. Characterization of reproductive hormonal dynamics in the perimenopauseResearchers who have studied this transition closely have concluded that FSH measurement is of little value during the menopausal transition because it cannot be interpreted reliably. Even after a postmenopausal-looking FSH level, ovulatory and presumably fertile cycles can still occur.
13European Journal of Endocrinology. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition—an analysis of FSH, oestradiol and inhibinPostmenopausal Levels
Once menstruation has stopped for good, the picture simplifies. FSH levels climb to roughly 10 to 15 times the premenopausal baseline and stay there, driven by the loss of ovarian inhibin and estradiol that once kept the pituitary in check.
13European Journal of Endocrinology. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition—an analysis of FSH, oestradiol and inhibinEven in postmenopause, though, FSH is not a flat line for everyone. Body weight plays a measurable role. In one large study, postmenopausal women in the obese range had average FSH levels around 42 mIU/mL, while overweight and normal-weight women averaged about 57 and 59 mIU/mL respectively.
14PubMed Central. Obesity and Reproductive Hormone Levels in the Transition to MenopauseThe reason appears to involve fat tissue’s ability to produce estrogen via aromatase, which partially substitutes for what the ovaries no longer supply and thus partially suppresses FSH. Additional research has found that FSH in postmenopausal women correlates negatively with body-mass index, body fat mass, and insulin resistance, and positively with adiponectin, even after adjusting for age and years since menopause.
15PubMed Central. Relationship between metabolic syndrome and follicle-stimulating hormone in postmenopausal womenNormal FSH in Men
Male FSH physiology gets less attention, partly because it does not swing with a monthly cycle. In adult men, FSH supports Sertoli cells in the testes, which nurture developing sperm. The standard lab reference range is typically listed as something like 1.5 to 12 or 1.4 to 18 mIU/mL, depending on the assay. But “normal” on a lab report does not always mean “optimal” for sperm production.
A study specifically examining male infertility found that an FSH level above 4.5 IU/L was already associated with abnormal sperm concentration and morphology. Men with levels above 7.5 IU/L had a five- to thirteen-fold higher risk of abnormal semen quality compared with men whose FSH was below 2.8 IU/L. The standard lab cutoff of around 18 IU/L as the upper limit of normal may therefore be far too generous when the clinical question is fertility.
16PubMed. Redefining abnormal follicle-stimulating hormone in the male infertility populationUnlike in women, FSH in men shows relatively little diurnal variation, so the time of day you draw blood matters less than it does for testosterone.
17The Journal of Clinical Endocrinology & Metabolism. The Effect of Diurnal Variation on Clinical Measurement of Serum Testosterone and Other Sex Hormone Levels in MenWhen FSH Is Abnormally Low
Very low FSH can be just as significant as very high FSH. In women, conditions that suppress the hypothalamus’s output of GnRH, such as functional hypothalamic amenorrhea from extreme exercise, severe calorie restriction, or chronic stress, lead to reduced pulsatile signaling. Because slower GnRH pulses favor FSH secretion over LH, the LH-to-FSH ratio drops, and both hormones end up lower than normal.
18PubMed Central. The LH:FSH Ratio in Functional Hypothalamic Amenorrhea: An Observational StudyIn both sexes, damage to or tumors of the pituitary itself can cause a broader deficiency called hypopituitarism, where production of FSH along with other pituitary hormones drops. The symptoms tend to creep in slowly and depend on which hormones are most affected. In the case of FSH deficiency, the result is impaired gonadal function: absent or irregular periods in women, and reduced sperm production in men. Measuring basal levels of pituitary hormones alongside their target-organ hormones is the standard way to sort out where the problem lies.
19PubMed Central. Diagnosis and Treatment of HypopituitarismWhen FSH Is Abnormally High in Young Women
An FSH level persistently in the postmenopausal range in a woman under 40 is a hallmark of premature ovarian insufficiency, sometimes called premature ovarian failure. The defining picture is amenorrhea combined with elevated gonadotropins and infertility before age 40.
20PubMed Central. Premature ovarian failureThis can happen for a variety of reasons, from genetic causes like Turner syndrome to autoimmune conditions to medical treatments. Certain chemotherapy regimens, for example, can damage ovarian tissue directly. In one study of women receiving cyclophosphamide and fludarabine as part of a cancer treatment protocol, over 40% of those in the chemotherapy-only group developed persistently elevated FSH and were diagnosed with premature ovarian failure, and all patients who also received total body radiation were affected.
21PubMed Central. Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapyWhy Lab Results Vary Between Hospitals
One frustrating reality about FSH testing is that the number you get depends partly on which assay your lab uses. A multicenter evaluation comparing several widely used immunoassay platforms found that some showed a positive bias for FSH while others showed a negative bias. Reference ranges at the low end varied widely even among laboratories running the same assay technology.
22PubMed. A multicenter evaluation of immunoassays for follicle-stimulating hormone, luteinizing hormone and testosterone: concordance, imprecision and reference valuesThis matters practically because a borderline FSH value at one lab might look normal or abnormal at another. If you are tracking FSH over time, whether for fertility treatment or monitoring menopause, sticking with the same laboratory and assay platform makes serial comparisons more reliable. The problem traces partly to the nature of FSH itself: the hormone exists in multiple molecular forms with different biological activities, and no single reference standard perfectly captures them all.
23Oxford Academic (Endocrine Reviews). Definition and Measurement of Follicle Stimulating HormoneHow Body Weight Shifts Your Numbers
Body composition is an underappreciated modifier of FSH, especially in women. In postmenopausal women, as already noted, higher body fat is associated with lower FSH, likely through fat-derived estrogen partially suppressing pituitary output. But the relationship is not limited to postmenopause. In a study of overweight, glucose-intolerant postmenopausal women who lost weight through a lifestyle intervention, FSH actually increased slightly, and the change in FSH correlated with weight loss even after accounting for changes in estradiol.
24PubMed Central. Weight loss results in a small decrease in follicle stimulating hormone in overweight glucose-intolerant postmenopausal womenFor someone interpreting their own FSH results, the takeaway is that two postmenopausal women of different body sizes can have meaningfully different FSH levels without either being abnormal for her own physiology. A clinician who sees a postmenopausal FSH of 42 in an obese patient and 59 in a normal-weight patient is likely looking at the same underlying state of ovarian quiescence, just filtered through different amounts of peripheral estrogen production.
FSH and Mental Health in Women
An emerging area of research links FSH not just to reproductive function but to brain health. The steep rise in FSH during the menopausal transition, reaching levels roughly 14 times those seen in men, coincides with a well-documented window of increased vulnerability to depression, anxiety, and cognitive complaints in women.
10PubMed Central. Follicle-stimulating hormone: More than a marker for menopause: FSH as a frontier for women’s mental healthWhether FSH itself is contributing directly to these symptoms, or is simply rising in parallel with the estrogen withdrawal that drives them, is still being worked out. But the sheer magnitude of the sex-specific difference in FSH levels during this life stage has drawn attention to the hormone as more than a passive marker. Some researchers now view FSH as a potential frontier for understanding why the menopausal transition carries such pronounced psychiatric risks for a subset of women. It is too early to know whether targeting FSH directly could improve mental health outcomes, but the correlation has moved beyond anecdote into structured investigation.